NICE recommends remote monitoring technology for heart failure patients
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020
Read More
Tag: heart failure
Study finds AI reduces underdiagnosis of Black patients with common heart failure
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
Read More
Study reveals heart failure device could monitor patients and prevent hospitalisation
Heart failure is a cardiovascular disease that affects more than 64 million people worldwide
Read More
NHS virtual wards to treat heart failure patients at home
Thousands of patients with heart failure are set to benefit from the expansion
Read More
Study reveals diagnosis and treatment inequalities in NHS heart care
Researchers focused on four of the most common heart conditions in the UK
Read More
AstraZeneca’s dapagliflozin recommended by NICE
Treatment concerns up to 150,000 patients in England with chronic heart failure
Read More
AstraZeneca’s Forxiga recommended in EU for chronic heart failure
Drug is the first heart failure medication to provide mortality benefit across entire ejection fraction range
Read More
Research positions Nordic Bioscience’s PRO-C6 as next-generation biomarker
The PRO-C6 biomarker assay has been transferred to Roche Diagnostics for further analysis
Read More
Heart failure med Jardiance scores MHRA approval
Marketing authorisation covers treatment of heart failure with reduced ejection fraction
Read More
Pirfenidone could offer ‘viable’ heart failure treatment
NIHR trial shows the lung drug could treat heart failure patients
Read More
MSD, Bayer’s heart failure med Verquvo gains EU approval
Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
Read More
Jardiance becomes first SGLT2 inhibitor to show benefit in HFpEF
Eli Lilly and Boehringer Ingelheim have revealed positive results from a Phase III study of Jardiance in HFpEF patients
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
